임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

39건 표시

1상모집 예정· Pneumonia, Bacterial
3회 기본 투여 후 12~15개월에 부스터 투여를 받는 영아의 시험용 폐렴구균 백신의 안전성 및 반응원성 평가 시험
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age
리드: GSK
상세 →NCT07406347
1상모집 예정· Multiple Myeloma
A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment
리드: GSK
상세 →NCT07609706
1상모집 예정· Asthma
A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
리드: GSK
상세 →NCT07712393
1상모집 예정· Urinary Tract Infections
A Study to Evaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating Women
리드: GSK
상세 →NCT07645235
1상모집 예정· Cough
A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes
리드: GSK
상세 →NCT07684586
1상모집 예정· Malaria, Falciparum
Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years
리드: GSK
상세 →NCT07670377
1상모집 예정· Salmonella Infections
A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVGH) Quadrivalent Pan-Salmonella Vaccine With and Without Alum in Healthy Young Adults
리드: GSK
상세 →NCT07663032
1상모집 예정· Malaria, Falciparum
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults
리드: GSK
상세 →NCT07646353
1상모집 예정· Pneumonia, Bacterial
A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose
리드: GSK
상세 →NCT07406334
1상모집 예정· Kidney Disease
A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive
리드: GSK
상세 →NCT07600450
1상모집 예정· Urinary Tract Infections
A Study in Pediatric Participants Aged ≥2 to <12 Years With a Suspected or Confirmed Bacterial Infection or Receiving Prophylaxis Antibiotics
리드: GSK
상세 →NCT07371429
1상모집 중· Neoplasms
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT07438782
1상모집 중· Non-alcoholic Fatty Liver Disease
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
리드: GSK
상세 →NCT07358546
1상모집 중단 (진행 중)· Pneumonia, Bacterial
Trial to Evaluate Safety and Immune Response of an Investigational Pneumococcal Vaccine in Adults Aged 50 To 64 Years
리드: GSK
상세 →NCT07428759
1상모집 중· Influenza, Human+COVID-19
A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
리드: GSK
상세 →NCT07464314
1상모집 중· Non-alcoholic Fatty Liver Disease
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry
리드: GSK
상세 →NCT07335198
1상모집 중· Myelofibrosis
Momelotinib During and After HCT in Myelofibrosis
협력: GSK
상세 →NCT07104799
1상모집 중· Systemic Lupus Erythematosus
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
리드: GSK
상세 →NCT07371468
1상모집 중· Neoplasms
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT07277270
1상모집 중단 (진행 중)· Hepatitis B
A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease
리드: GSK
상세 →NCT07168356
1상모집 중· Streptococcal Infections
A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
리드: GSK
상세 →NCT07085702
1상모집 중단 (진행 중)· Kidney Disease
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
리드: GSK
상세 →NCT06734234
1상모집 중단 (진행 중)· Colitis, Ulcerative
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants
리드: GSK
상세 →NCT06681181
1상모집 중· Neoplasms
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
리드: GSK
상세 →NCT06551142
1상모집 중단 (진행 중)· Respiratory Syncytial Virus Infections
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
리드: GSK
상세 →NCT06573281
1상모집 중· Systemic Lupus Erythematosus
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
리드: GSK
상세 →NCT06576271
1상모집 중· Asthma
A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive
리드: GSK
상세 →NCT06433921
1상모집 중· Solid Tumors
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
리드: GSK
상세 →NCT06431594
1상모집 중단 (진행 중)· Pulmonary Disease, Chronic Obstructive
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
리드: GSK
상세 →NCT06154837
1상모집 중· Endometrial Cancer
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
협력: GSK
상세 →NCT05819892
1상모집 중· Metastatic Solid Tumor
Combination Therapy in Cancers With Mutations in DNA Repair Genes
협력: GSK
상세 →NCT05694715
1상모집 중· HIV Infections
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
협력: GSK
상세 →NCT05418868
1상모집 중단 (진행 중)· Neoplasms
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT05277051
1상모집 중단 (진행 중)· Anatomic Stage III Breast Cancer AJCC v8
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
협력: GSK
상세 →NCT04673448
1상모집 중단 (진행 중)· Multiple Myeloma
A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
리드: GSK
상세 →NCT04398745
1상모집 중단 (진행 중)· Advanced Solid Tumor
Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer
협력: GSK
상세 →NCT04502602
1상모집 중단 (진행 중)· Neoplasms
Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT04446351
1상모집 중단 (진행 중)· Multiple Myeloma
Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
리드: GSK
상세 →NCT04091126
1상모집 중단 (진행 중)· Neoplasms
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
리드: GSK
상세 →NCT03843359

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.